RTIX Insider Trading Activity and SEC Form 4 Filings
RTIX insider trading summary
No open-market insider purchases or sales of Rti Surgical, Inc. (RTIX) have been reported on SEC Form 4 in the past 12 months.
Latest RTIX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 12, 2018 | Jonathon M Singer | CFO/CAO | Buy | $214K (50,000 @ $4.28) |
| Dec 10, 2018 | Camille Farhat | Chief Executive Officer | Buy | $44K (11,516 @ $3.85) |
| Dec 6, 2018 | Camille Farhat | Chief Executive Officer | Buy | $69K (17,185 @ $4.04) |
| Aug 21, 2017 | Nicholas J Valeriani | Director | Buy | $26K (5,500 @ $4.70) |
| Aug 11, 2017 | John N Varela | EVP Global Operations | Buy | $58K (12,000 @ $4.85) |
| May 18, 2017 | Camille Farhat | Chief Executive Officer | Buy | $287K (61,693 @ $4.65) |
| May 8, 2017 | Shirley A Weis | Director | Buy | $10K (2,200 @ $4.58) |
| May 5, 2017 | Mark Stolper | Director | Buy | $23K (5,000 @ $4.57) |
| May 4, 2017 | Nicholas J Valeriani | Director | Buy | $25K (5,500 @ $4.60) |
| May 3, 2017 | Kevin D Brandt | Insider | Buy | $150K (33,130 @ $4.52) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.